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To identify functions of the fragile tumour suppressor gene, FHIT, matched pairs of Fhit-negative and -positive human cancer cell
clones, and normal cell lines established from Fhit  /  and þ/þ mice, were stressed and examined for differences in cell cycle
kinetics and survival. A larger fraction of Fhit-negative human cancer cells and murine kidney cells survived treatment with mitomycin
C or UVC light compared to matched Fhit-positive cells; B10-fold more colonies of Fhit-deficient cells survived high UVC doses in
clonigenic assays. The human cancer cells were synchronised in G1, released into S and treated with UVC or mitomycin C. At 18h
post mitomycin C treatment B6-fold more Fhit-positive than -negative cells had died, and 18h post UVC treatment 3.5-fold more
Fhit-positive cells were dead. Similar results were obtained for the murine  /  cells. After low UVC doses, the rate of DNA synthesis
in  /  cells decreased more rapidly and steeply than in þ/þ cells, although the Atr–Chk1 pathway appeared intact in both cell
types. UVC surviving Fhit  /  cells appear transformed and exhibit 45-fold increased mutation frequency. This increased mutation
burden could explain the susceptibility of Fhit-deficient cells in vivo to malignant transformation.
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FHIT gene structure and protein expression have been examined
in detail in many types of cancers (for a review, see Huebner and
Croce, 2003). Fhit expression is reduced or absent in the majority
of human cancers due to genetic or epigenetic modification,
though point mutations are very rare. The Fhit signalling pathway
is of interest because the FHIT gene, in mouse and human, spans
an active common chromosomal fragile site, that is susceptible to
DNA damage due to intrinsic or extrinsic agents, including
inhibitors of DNA replication, such as aphidicolin, the agent used
to induce expression of common fragile sites. Replacement of Fhit
in most Fhit-deficient cancer cells suppresses tumorigenicity
(Siprashvili et al, 1997; Ishii et al, 2001; Sevignani et al, 2003)
and FHIT-viral gene therapy, using adeno or AAV viral vectors,
prevents and reverses carcinogen-induced gastric cancers in Fhit-
deficient mice (Dumon et al, 2001; Ishii et al, 2003). Recombinant
mice carrying one or two inactivated Fhit alleles are viable and
long-lived but show increased rates of spontaneous and carcino-
gen-induced cancers (Fong et al, 2000; Zanesi et al, 2001); thus,
Fhit-deficient mice are excellent models for preclinical studies of
tumour development, prevention and therapy. From the extensive
studies of the human and murine FHIT loci since its 1996
discovery, it is known that Fhit overexpression can cause death of
Fhit-deficient cells through apoptosis (Ji et al, 1999; Sard et al,
1999; Dumon et al, 2001), while normal and Fhit-sufficient cells are
unharmed; some details of the intrinsic apoptotic pathway
activated in Fhit-positive cells have been reported (Ji et al, 1999;
Dumon et al, 2001; Ishii et al, 2001; Sevignani et al, 2003).
Nevertheless, in the absence of confirmed interacting proteins, it
has been difficult to define downstream effectors of Fhit signalling.
We have used both human and mouse, Fhit-positive and -negative
cells in vitro, to compare phenotypes of the two genotypes after
exposure to various stressful conditions, such as low serum,
detachment from substrate, hypoxia, irradiation and genotoxic
drugs. We have observed that exposure to mitomycin C and UVC
induces a phenotypic difference between Fhit-deficient and -
sufficient cells, with the deficient cells showing a striking survival
advantage after both treatments. To define the phenotypic
difference in detail, with the elucidation of the Fhit signal pathway
as the ultimate goal, we have performed survival, clonigenicity, cell
cycle kinetics, rate of DNA synthesis and mutation rate analyses
after exposure to mitomycin C and UVC treatments.
MATERIALS AND METHODS
Establishment and maintenance of cells
M1 Fhit  /  and þ/þ kidney cells were established in culture
from whole mouse kidney. Mice were killed using CO2 and
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ydissected to obtain the kidney in accordance with guidelines of the
TJU IACUC. Kidney tissue was disaggregated in RPMI medium
(GIBCO, Carlsbad, CA, USA) supplemented with 10% FBS and
100mgml
 1 gentamicin. The cells were subcultured when they
reached confluence. NIH Swiss kidney (Fhit þ/þ) cells were
maintained in MEM (GIBCO) supplemented with 10% FBS and
100mgml
 1 gentamicin. The mouse cell lines showed near diploid
karyotypes at passage 25 or earlier; the  /  cell line had an
average of 42.6 chromosomes (range 41–44, with two marker
chromosome) the þ/þ cell line showed two populations with
60% of cells with an average of 43 chromosomes with a few
markers and 40% of cells hypotriploid (average chromosome
number 72, with 0–7 markers). MKN74 cells are a human gastric
cancer cell line lacking Fhit expression. The clones used in these
experiments are A66 and A116 (Fhit þ) and E4 (empty vector)
(Siprashvili et al, 1997). Fhit  /  UV1 cells were established from
a surviving clone after treatment with 30Jm
 2 UVC. These cells
appear transformed and grow to a saturation density five-fold
greater than the saturation density of the Fhit  /  parental cells.
H1299, a lung tumour cell line stably transfected with the
ecdysone-inducible vector pVgRXR (Invitrogen, Grand Island,
NY, USA) was obtained from Dr Jennifer Pietenpol. These cells
were then stably transfected with pIND-Fhit and clones tested for
expression of Fhit before and after induction with 1mM Ponaster-
one A. Western blotting of clone D1 showed no Fhit expression
without Ponasterone A and a steady increase after induction.
Determination of cell growth (MTS assay)
In vitro cytotoxicity was assessed by 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulphenyl)-2H-tetrazolium, in-
ner salt (MTS) assay, as previously described (Lee et al, 2001).
Cells were seeded in microtitre plates and 24h later drugs were
added and serially diluted. The cells were incubated at 371C for
72h, at which time MTS and phenazine methosulphate were
added. The absorbance was read at 492nm, and the resulting OD
was proportional to the number of viable cells.
Induction of apoptosis (TUNEL analysis)
Fhit-positive and -negative cells were seeded in six-well plates, and
the next day treated with drugs for 24h. Cells were collected by
trypsinisation and evaluated for apoptosis by TUNEL assay (APO-
Direct Kit, BD Biosciences Pharmingen, San Diego, CA, USA). Data
acquisition and analysis was performed on a FACScalibur flow
cytometer from Beckton and Dickinson. Doublet discrimination
gates were set prior to analysis using the Cellquest software, also
from Beckton and Dickinson.
Stress induction
Mitomycin C: Cells were seeded in 100mm dishes, and allowed to
attach and cycle for 16–24h. Cells were then treated with medium
supplemented with 2 or 5mM mitomycin C for specified times. UVC
irradiation: Using a 254nm UVC lamp (ULTRA LU ˆM, Inc,
Paramount, CA, USA) which was calibrated each time before
using, cells were exposed to 60Jm
 2 UVC for some experiments;
lower doses, 3–30Jm
 2, were used for specified experiments.
Survival and cell cycle kinetics assays
For survival assays, cells were counted, seeded in 100mm dishes
and left to grow for 16–24h. Cells were either left untreated or
exposed to UVC or mitomycin C and incubated for the specified
periods. Attached cells were trypsinised, counted and compared at
the collection time points. In some experiments, viable cells
(attached and floating) were detected by Trypan blue dye exclusion
after UVC exposure. Results of these experiments represent the
percent of treated cells excluding Trypan blue in comparison to
untreated cells. For assessment of clonigenicity, cells were seeded
to 100mm dishes and left to grow for 16–24h. Cells were
untreated or exposed to UVC or mitomycin C and then
trypsinised, counted and re-seeded to 100mm dishes at specified
cell densities and incubated for up to 18 days for colony formation.
Flow cytometry analysis
Cells were treated with UVC, mitomycin C or left untreated. At
specified times, cells were collected by trypsinisation, washed with
PBS and re-suspended in cold 70% ethanol. Fixed cells were stored
at  201C overnight. For analysis, cells were spun down, washed in
PBS and suspended in propidium iodide (PI)/Triton X-100
staining solution (0.1% Triton X-100, 20mgml
 1 PI, 0.2mgml
 1
of DNase-free RNase A (in PBS)). Cells were stained for 30min at
room temperature and flow cytometric analysis was performed.
For S-phase BrdU labelling, cells were pulsed for 1h with 10mM
BrdU (Sigma), then treated or left untreated and incubated for the
specified times. Cells were collected and fixed in cold 70% ethanol.
Fixed cells were treated in denaturing buffer (2 M HCl), washed
(PBS, 0.5% BSA) and incubated for 20min at room temperature in
anti-BrdU monoclonal antibody (Pharmingen, San Diego, CA,
USA). Cells were washed, resuspended in PI (10mgml
 1 in PBS)
and incubated at room temperature for 30min. Fixed, stained cells
were analysed by flow cytometry using a Beckman Coulter XL
analyzer, with a 488nm argon ion laser, and results were analysed
using System II Software (Beckman Coulter, Hialeah, FL, USA).
Cell synchronisation
Cells were synchronised by seeding in 100mm dishes in growth
medium, allowing attachment (5–7h), and replacing the medium
with 0.1% (for gastric cancer cells) or 1% FBS (for murine cell
lines) in MEM for 72h. The medium was again replaced with 10%
FBS-MEM for 24h before the addition of 9mM aphidicolin for 16h.
The cells were washed in PBS and re-fed with complete medium for
varying release times before UVC or mitomycin C treatment.
Rate of DNA synthesis
The S-phase (S) checkpoint was detected by measuring DNA
synthesis by a method similar to that described previously
(Paulovich and Hartwell, 1995). Briefly, 1 10
5 cells from a
growing culture were seeded in 60-mm tissue culture dishes with
3ml of medium and allowed to grow for more than one doubling.
Cells were then pre-labelled in medium containing 10nCi of
[
14C]thymidine and 0.5mM cold thymidine. Pre-labelling provides
an internal control for cell number by allowing normalisation for
the total DNA content of samples. Before irradiation, the medium
was replaced with pre-warmed medium and cells were exposed to
3, 5 or 10Jm
 2 at room temperature and returned to 371C.
[
3H]thymidine at 0.5mCi was added for 30min at different times
after UVC. The cells were then collected and the rate of DNA
synthesis for each sample was calculated as
3H/
14Cd.p.m. and
presented as a percentage of the control values obtained from
sham-irradiated cells at the same time point, as described
previously (Zhou et al, 2002).
The rate of DNA synthesis was also examined by a BrdU
incorporation method. Fhit þ/þ and  /  cells were incubated at
371C for 24h, and then mock-treated or treated with UVC at
indicated doses. After 30min, 10mM BrdU (Sigma) was added for
1h. Cells were then harvested and fixed in 70% ethanol at 41C
overnight. Samples were washed twice with PBS, incubated in 2 N
HCl/0.5% Triton X-100 (vv
 1) at room temperature for 30min,
followed by 0.1 M sodium borate for 2min and washed twice with
PBS containing 0.5% Tween 20/0.5%BSA. After that, samples were
incubated for 20min with 2ml of anti-BrdU-FITC (Pharmingen).
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0.5%BSA, cells were incubated for 30min with 100mgml
 1, RNase
and 10mgml
 1 PI, and analysed by flow cytometry. Cell staining
using anti-mouse IgG1 FITC-labelled antibody was used to set the
background green fluorescence. At least 10000 events were gated
for each experiment.
Mutation frequency
Fhit /  and  /  UV1 were seeded in T175 flasks (1.65 10
8 cells
total) in a medium containing 6-thioguanine (6TG, 3 10
 6 M)
and cultured for 3 weeks. The number of surviving colonies per 10
7
cells was calculated for each cell type.
Western blot analysis
Protein was prepared by lysing cells in a solution of 30mM Tris
(pH 7.5), 10% glycerol, 150mM NaCl and 1% NP40 with proteinase
inhibitors. Approximately 75mg of total protein was electrophor-
esed on 12% SDS–PAGE gels, transferred to membrane and
blocked in 5% dry milk for 1h before incubation with primary
antibodies against Chk1 (sc-8408, Santa Cruz Biotechnology Inc,
Santa Cruz, CA, USA), Phospho-Chk1 (23415, Cell Signaling
Technology Inc, Beverly, MA, USA), Cdc25A (sc-7389, Santa Cruz
Biotechnology Inc), GAPDH (MAB374, Chemicon International,
Temecula, CA, USA) or Fhit (Fong et al, 2000). Membranes were
incubated in the appropriate secondary antibody labelled with
HRP and the signal detected with Super Signal Chemi-luminescent
Substrate (Pierce, Rockford, IL, USA).
RESULTS
Characteristics of Fhit-positive and -negative cells
Cancer cell clones selected for expression of exogenous Fhit show
similar in vitro growth characteristics when compared to sister
clones transfected with vector only (Siprashvili et al, 1997).
Likewise, normal kidney cells from Fhit þ/þ and  /  mice,
established in culture, show similar doubling times and growth
factor requirements (data not shown). So what sort of function
could Fhit be involved in if its effect is observed through
suppression of growth in vivo but not in vitro? One possibility is
that Fhit could be involved in responses to external signals, such as
stress inducers, and a number of agents were tested, including
staurosporine, peroxide, hypoxia, ultraviolet and ionising radia-
tion, and cytostatic and genotoxic drugs. We first examined
MKN74 gastric carcinoma cells, clone MKN74E4, that lack Fhit
expression due to homozygous deletion of coding exons, in
comparison to MKN74A66 and A116 cells expressing exogenous
FHIT cDNA. Genotoxic agents, mitomycin C and camptothecin
induced dose-dependent decreases in cell growth in all the three
cell lines; however, the Fhit-positive cells were significantly more
sensitive than the Fhit-negative cells (Figure 1A). At the IC50
concentration, these differences were 36- and eight-fold for
mitomycin C and camptothecin, respectively. Consistent with the
cell growth data, a greater increase in induction of apoptosis due to
these compounds was observed in the Fhit-positive cells than in
the Fhit-negative cells, at each concentration tested (Figure 1B,
TUNEL assay). The differences tended to be greater at higher
drug concentrations, as apoptosis was measured after 24h drug
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Figure 1 Effect of genotoxic agents on cell growth and apoptosis induction in Fhit-positive (MKN74A66 and A116) and Fhit-negative (MKN74E4) gastric
tumour cell lines. (A) Cell growth after 72h exposure to mitomycin C or camptothecin, determined by MTS tetrazolium dye conversion assay. (B) Induction
of apoptosis after 24h exposure to mitomycin C or camptothecin determined by TUNEL assay.
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survival assays.
Enhanced survival of the Fhit  /  normal mouse kidney cells
after UVC light treatment was the first evidence for an in vitro
phenotypic effect of Fhit deficiency in otherwise normal cells
(Figure 2A). The MKN74A66 and E4 cells were then treated with
60Jm
 2 UVC and the Fhit-negative E4 cells were found to be UVC
resistant in a clonigenicity assay (Figure 3B), while the Fhit  / 
cells were also found to be mitomycin C resistant in viability assays
(Figure 2B). Human lung carcinoma cells, H1299 (Fhit  and
p53 ), were transfected with the ecdysone-inducible vectors,
pVgRXR and pIND-Fhit. Clone H1299D1 was cultured with
(Fhitþ) or without (Fhit ) Ponasterone A, treated with 60Jm
 2
UVC and percent survival calculated after various times. More
than twice as many Fhit  cells survived 20 and 24h post UVC
(Figure 2C). Expression of Fhit protein in Fhit-transfected cells
used for these studies is shown in Figure 2D.
A clonigenicity assay showed that after high-dose UVC
treatment, B10-fold more colonies grew on the plates seeded
with Fhit-deficient normal mouse cells and the Fhit-deficient
gastric cancer cells (Figure 3B, D), although the positive and
negative cell pairs have similar plating efficiencies. Dose–response
curves for inactivation of colony formation by UVC are shown in
Figure 3A, C. The slopes of the lines for relative colony formation
vs UVC dose are an indication of the effect of Fhit expression on
UVC sensitivity in murine kidney and human gastric cancer cells.
Colonies were selected from the Fhit  /  and þ/þ dishes of
UVC surviving clones, and were tested in a second exposure to
60Jm
 2 UVC to determine if surviving clones had developed
mutations that caused UVC resistance. The surviving clones
showed UVC sensitivities similar to the parental Fhit þ/þ and  /
  cell lines (data not shown). Additionally, karyotypes of the UVC
survivor clones exhibited near-diploid karyotypes (model chromo-
some number 42.6), very similar to the near-normal (model
chromosome number 42) karyotype of the parental Fhit  /  cells;
the majority of Fhit  /  cells before and after UVC exhibited
trisomy 19 and some cells showed trisomy 12 and/or marker
chromosome(s) (data not shown).
A dose–response curve (Figure 4) for Fhit-deficient murine cells
showed that even at 10Jm
 2 UVC there was a large difference in
viability of Fhit  /  and þ/þ cells 24h after treatment.
Cell cycle analyses
To clarify biological events occurring after exposure to UVC or
mitomycin C, we compared cell cycle profiles of Fhit-positive cells
to the respective Fhit-deficient murine or human cells, with and
without treatment. In pilot experiments, Fhit-deficient human and
mouse cells consistently showed B10% more cells in S phase and
B10% fewer cells in G1, under normal growth conditions (not
shown); after UVC or mitomycin C, the main difference observed
in the cell cycle profiles was that up to 40% of the Fhit-positive
cells were sub-G1 in DNA content (apoptotic/necrotic) relative to
fewer than 10% of the Fhit-deficient cells, both mouse and human,
by 20h after UVC treatment of mouse or mitomycin C treatment of
human or vice versa (not shown). This implied that Fhit-deficient
cells remained in S and G2/M phases of the cell cycle longer after
stress exposure, while Fhit-positive cells cycled more rapidly and
damaged cells became apoptotic. To investigate the cell cycle
profiles following stressful exposures, the murine and human cell
pairs were synchronised in G1, released into S phase and then
treated with UVC or mitomycin C. Results of representative
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Figure 2 Enhanced survival of Fhit-deficient cells after UVC and mitomycin C treatment. (A) Graphic representation of the percent of cells surviving after
60Jm
 2 UVC treatment. Fhit-positive cells undergo UVC-induced apoptosis, as seen in the decreasing percent of surviving cells. Fhit-negative cells do not
show a decrease in survival until 20h after UVC treatment, and show two-fold more surviving cells by 28h after treatment (Po0.0001, for difference
between the decrease in survival of þ/þ and  /  cells at 28h). (B) Fhit þ/þ and  /  cells were treated with 5mM mitomycin C and surviving fractions
determined. Fhit þ/þ cells demonstrate a gradual decrease in survival over time, whereas Fhit  /  cells continue to proliferate before a more gradual
decrease in survival. (Two-tailed t-test reveals that decrease in survival at 24h is significant (P¼0.0079).) Survival experiments were in duplicate or triplicate.
Two-tailed Fisher’s exact test computed at http://www.matforsk.no/ola/fisher.htm. (C) H1299D1þP (Fhit positive) and H1299D1-P (Fhit negative) cells
were exposed to 60Jm
 2 UVC. Fhit-positive cells died rapidly while Fhit-negative cells show a survival rate 460% at 24h post UVC (Po0.0001 for survival
difference at 24h). (D) Expression of Fhit protein in Fhit-transfected cells. Lane 1: H1299D1, no induction; lanes 2–5: H1299D1 after Ponasterone A
induction for 16, 24, 48, 96h, respectively; lane 6: MKN74E4; lane 7: MKN74A66; lane 8: MKN74A116; lane 9: human lung tissue. The higher Fhit band in
lanes 7 and 8 is a result of the FLAG tag (Siprashvili et al, 1997). Lane 9 shows a small amount of phosphorylated Fhit (Pekarsky et al, 2004).
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yexperiments are shown in Figure 5. After aphidicolin synchronisa-
tion and release into S phase, the Fhit-positive and -negative cells
exhibit similar profiles with around 50% of cells in S phase at the
time of mitomycin C or UVC treatment. At 21h after UVC
(30Jm
 2), 28% of A66 cells were dead relative to only 8% of E4
cells. Similarly, at 21h after 5mM mitomycin C exposure, 33.5% of
A66 cells were dead compared to only 6% of E4 cells (see Figure 5
for details). It is also notable that E4 cells show an increase in the
G1 fraction to 52% at 21h post UVC, suggesting that cells have
successfully passed the G2/M block and reentered G1, while in the
21h UVC-treated A66, the cells that have exited S/G2/M went into
apoptosis. After 21h of mitomycin C, on the other hand, the
majority of E4 cells seem to be cycling normally.
DNA synthesis in Fhit-deficient cells
Both UVC and mitomycin C damage engage the ATR–CHK1 DNA
damage checkpoint (Paulovich and Hartwell, 1995; Wright et al,
1998; Guo et al, 2000; Liu et al, 2000; Papouli et al, 2000; Zhao and
Piwnica-Worms, 2001; Lambert et al, 2003). Thus, we next
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Figure 3 Clonigenicity of UVC-treated Fhit-positive and -negative cells. (A) Dose–response clonigenicity for Fhit-positive and -negative A66 and E4 cells,
respectively. MKN74E4 and A66 cells were seeded (3000cellsdish
 1) after no treatment, or 5, 10, 15 and 30Jm
 2 UVC. After 14 days, cells were fixed in
methanol and stained with Giemsa. The values plotted are the averages from two separate experiments, containing three replica plates each. (B) MKN74E4
(Fhit negative) and MKN74A66 (Fhit positive) cells were exposed to 60Jm
 2 UVC, collected, counted and re-seeded (7500 per dish). After 18 days plates
were fixed in 1:1 methanol:acetone, stained with Giemsa and colonies counted. E4 cells formed an average of 300 colonies/7500cells and A66 an average
of 30 colonies/7500cells. The absence of Fhit confers an advantage in surviving the lethal dose of UVC. (C) Dose–response clonigenicity for Fhit þ/þ and
 /  mouse cells. The cells were seeded (3000cellsdish
 1) after no treatment or 5, 10, 15 or 30Jm
 2 UVC. After 14 days, the cells were fixed and stained.
The averages from two separate experiments, containing three replica plates each, are shown. (D) Fhit þ/þ and  /  cells were exposed to 60Jm
 2
UVC, collected, counted and re-seeded to dishes (5000 per dish). After 18 days, plates were fixed in 1:1 methanol:acetone, stained with Giemsa and
colonies counted. Fhit  /  cells formed an average of 90 colonies/5000cells and þ/þ cells an average of 10 colonies/5000cells.
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DNA synthesis in Fhit þ/þ and  /  cells early after low doses of
UVC irradiation were calculated after
3H[TdR] labelling as
described (Zhou et al, 2002). The rate of DNA synthesis after 3,
5 and 10Jm
 2 was determined by
3H[TdR] labelling assay and
results are shown in Figure 6A. At 6h after irradiation with
10Jm
 2 UVC, DNA synthesis in the  /  cells had declined by
470%, while in þ/þ cells the reduction was only 45%. From
these results, it is clear that the rate of DNA synthesis declines
more rapidly and steeply in Fhit  /  cells than in þ/þ cells in
response to increasing UVC doses. The rate of DNA synthesis
determined by BrdU showed a similar tendency (data not shown).
At 15Jm
 2, at 1.5h after UVC, DNA synthesis was reduced by 60%
in  /  cells but by only B24% in þ/þ cells; at 30Jm
 2, DNA
synthesis was reduced by more than 80% in  /  cells compared to
about 50% in þ/þ cells. The enhanced inhibition of DNA
synthesis in  /  cells occurred at each dose and time tested,
whether assessed by the isotopic or BrdU method.
To examine the DNA damage checkpoint in more detail, we next
examined expression of Chk1 and Cdc25A, the effectors down-
stream of Atr in this pathway. As shown in Figure 6B,
phosphorylated Chk1 is expressed in both þ/þ and  /  cells
after UVC treatment and Cdc25A decreased in Fhit  /  cells after
UVC, suggesting that the Chkl pathway is activated by UVC in
both cell types, with a suggestion of a higher level of
phosphorylation of Chk1 in Fhit  /  cells (see Figure 6B),
consistent with the dramatic decrease in DNA synthesis.
Experiments to determine the rate of DNA synthesis of the
MKN74A66 and E4 cells by BrdU incorporation after UVC
treatment showed a decline in DNA synthesis rate of only 20%
in A66 cells and 10% in the E4 cells after 60Jm
 2 UVC (data not
shown), suggesting that the DNA replication checkpoint pathways
are not intact in these cancer cell clones, although the Fhit-negative
E4 cells, like the Fhit  /  murine cells, traversed the S/G2/M
phases without undergoing apoptosis, while 30–40% of the A66
Fhit-positive cells were apoptotic at 18–20h after 30 or 60Jm
 2
UVC, as described above and shown in Figure 5.
Mutation frequency in UVC survivors
Since Fhit-deficient cell lines are resistant to apoptosis after UVC
and mitomycin C treatment, the surviving cells are likely to carry
misrepaired DNA damage. We tested this conclusion by growing
1.65 10
8Fhit-deficient and UVC-surviving Fhit-deficient cells in
6-thioguanine and counting surviving colonies, as an assay for
frequency of HPRT mutations. The Fhit  /  cells exhibited an
average of 2.7 colonies per 10
7 cells and UV-surviving UV1 cells
exhibited an average of 15 colonies per 10
7 cells, a difference of
5.6-fold. Similarly, the Fhit-deficient MKN74E4 UV survivor cells
showed 2.3-fold more 6TG-resistant colonies than the E4 cells. The
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Figure 4 Dose response of Fhit þ/þ and  /  cells to UVC treatment.
Fhit þ/þ and  /  cells were treated with various doses of UVC, as
indicated on the graph legend, collected and stained with trypan blue to
determine the fraction of viable cells at each time point. At doses of
20Jm
 2 or higher, Fhit þ/þ cells consistently demonstrate lower viability.
Figure 5 UVC and mitomycin C induced cell death in Fhit-positive but not in Fhit-negative cells. Cells were synchronised first by growth in low serum and
then by aphidicolin treatment for 16h. Cells were released into S phase for 3–5h and then left untreated (control) or mitomycin C or UVC treated. FACs
analysis was performed at 18–21h afterward, as shown for a representative experiment (21h). The fraction of cells in specific phases of the cell cycle are
illustrated in the bar graph and listed in the table below the bar graph.
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with the interpretation that the Fhit-negative UVC-surviving cells
have sustained unrepaired or misrepaired DNA damage, which
could underlie the susceptibility of Fhit-deficient cells to neoplastic
transformation.
DISCUSSION
A recent review (Skorski, 2002) on oncogenic tyrosine kinases
summarised as follows: ‘mutation or overexpression of oncogenes,
such as constitutively activated tyrosine kinases, can induce
uncontrolled growth, protection from apoptosis, enhanced repair
of DNA lesions, prolonged activation of cell-cycle checkpoints
providing more time for repair of lethal lesions, upregulation of
anti-apoptotic members of the BCL2 family, protecting cells from
apoptotic signals. The unrepaired and aberrantly repaired DNA
lesions that result from DNA damage can thus accumulate in the
oncogene expressing tumour cells, leading to genomic instability
and malignant progression.’ The results of the experiments
described here suggest the conclusion that loss of Fhit protein
function results in acquisition of features similar to those of an
oncogene-transformed cell: protection from apoptosis, rapid
activation of DNA damage checkpoint and accumulation of
mutations due to lesion misrepair. Thus, we considered the idea
that Fhit may be involved in signal pathways that intersect with an
oncogenic tyrosine kinase signal pathway, similar to the activated
Abl tyrosine kinase pathway. We have preliminarily investigated
this possibility by determining if inhibition of Abl activity in our
Fhit plus and minus cells might abrogate differences in UVC or
mitomycin C responses. Inactivation of the Abl kinase by STI571
(Gleevec) treatment of Fhit-positive and -negative cells did not
alter the response to mitomycin C or UVC, suggesting that Abl
tyrosine kinase is not part of the Fhit pathway (unpublished data).
As also pointed out by Skorski, oncogenic tyrosine kinases make
good targets for antitumour treatments and some such treatments
are in clinical trials. Well-known tumour suppressor genes such as
TP53 and CDKN2A, encoding p53 and p16, similarly affect cell
cycle checkpoint, apoptotic and repair pathways; absence of the
wild-type p53 or p16 proteins has effects on cell cycle kinetics,
response to DNA damage and apoptosis, but these proteins are not
necessarily good targets for treatment, except through gene
therapy, necessitating identification of effectors of tumour
suppressor signalling pathways, to define new therapeutic targets.
In an approach to define the Fhit tumour suppressor signal
pathway, we have developed in vitro models to study the effects of
absence of Fhit on cellular stress responses. Of the stress inducers
tested (staurosporine, hypoxia, chemotherapeutic agents, detach-
ment from substrate, H2O2, ionomycin (M Ottey et al, unpub-
lished)), UVC and mitomycin C induced significantly decreased
levels of apoptosis and increased cell survival in Fhit-negative cells.
Both UVC and mitomycin C treatment cause DNA crosslinks, a
severe form of DNA damage, and both agents induce the DNA
damage checkpoint initiated by the activation of Atr and Chk1
kinases (Guo et al, 2000; Liu et al, 2000; Papouli et al, 2000; Zhao
and Piwnica-Worms, 2001; Heffernan et al, 2002; Unsal-Kacmaz
et al, 2002). In addition, the topoisomerase I poison, camptothecin,
which produces single-strand DNA breaks, also results in the
activation of the Atr/Chk1-regulated S-phase checkpoint (Wang
et al, 2002). This DNA-damaging agent likewise induced apoptosis
in MKN74A66 Fhit-positive cells, but less so in E4 Fhit-negative
cells.
ATM and ATR genes are both activated by DNA damage, with
ATM responding mainly to double-strand breaks, such as induced
by ionising radiation, and ATR reacting to UV or stalled
replication forks (for a review, see Yang et al, 2003). Specifically,
ATR functions in UVC-induced signalling and apoptosis (Wright
et al, 1998; Heffernan et al, 2002). The ATR pathway appears intact
in Fhit-deficient cells and there is some suggestion that the ATR
pathway is, in fact, enhanced in Fhit-deficient mice. For example,
DNA synthesis is more rapidly inhibited in Fhit  /  cells after low
UVC doses.
The unique phenotype of Fhit-deficient cells, with their rapid
and prolonged block in S/G2 after UVC or mitomycin C treatment,
coupled with drastically reduced apoptotic response, suggests that
Figure 6 (A) The rate of DNA synthesis after UVC treatment in Fhit
þ/þ and  /  cells. DNA synthesis was examined at 1.5 and 6h after
various doses of UVC treatment in Fhit þ/þ and  /  cells. The cells pre-
labelled with
14C[TdR] were changed with pre-warmed medium before
UVC. At 1 and 5.5h after exposure to different doses of UV, 0.5mM
3H[TdR] was added to the cell culture. After 30min, the cells were
collected and loaded on GF-A filtres set in a Millipore Vacuum chamber.
The rate of DNA synthesis for each sample was calculated as
3H/
14Cd.p.m.
and is presented as a percentage of the control values obtained from
untreated cells at the same time point. The data are presented as mean
values and standard deviations from three independent experiments. (B)
The CHK1 pathway is activated in UVC-treated Fhit-positive and -negative
cells. The Fhit þ/þ and  /  cells were treated with UV (15Jm
 2)o r
untreated and harvested 2h post treatment. Equal amounts of whole-cell
extract were immunoblotted with antibodies against Chk1, phospho-Chk1
and Cdc25A, respectively. GAPDH antibody was used as the internal
control for equal loading. Similar results were obtained from two
independent experiments.
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important in the development of precancer and cancer. The result
of the alterations to the DNA damage response is that Fhit-
deficient cells escape their legitimate death sentence, with some of
them carrying unrepaired or misrepaired DNA lesions that will
contribute to further clonal expansion, as shown by the
transformation and increased HPRT mutations exhibited by the
UVC-surviving colonies.
In fact, loss of most genes involved in DNA damage checkpoints
or DNA damage repair, such as ATM, ATR, BRCA1, BRCA2,
Fanconi anemia genes, lead to increased sensitivity to genotoxic
agents. All of these can be considered as tumour suppressor genes
whose loss leads to increased DNA damage. Loss of Fhit leads to
reduced sensitivity to the DNA crosslinking agents UVC and
mitomycin C. If Fhit were a checkpoint gene, then we would not
expect to see the rapid inhibition of DNA synthesis in Fhit  / 
cells after UVC treatment (Figure 6A). Perhaps Fhit protein
actually slows the response to UVC by, for example, binding to
Hus1 or another member of the 9-1-1 complex (Roos-Mattjus et al,
2002; Weiss et al, 2002) to slow movement into the nucleus. This
may prevent a too drastic response to low-dose genotoxic agents.
But Fhit protein must have an effect also at the G2/M checkpoint
when assessment of DNA damage repair takes place before re-
entering the cell cycle. At this point, after 30–60Jm
 2 UVC, the
Fhit-positive cells are correctly assessed as harbouring unrepaired
DNA that triggers apoptosis, while the similarly treated Fhit-
negative cells go through mitosis and back into G1, still carrying
improperly repaired or unrepaired DNA lesions, as suggested by
the higher mutation rate of the Fhit  /  UV survivors. There are
no reports of other genes for which inactivation enhances cell
survival after UVC exposure. We are currently examining in detail
the proteins involved in progression through late S/G2/M, to
determine where signal pathways may diverge in Fhit-positive and
-negative cells.
We have known for some time that Fhit protein is, directly or
indirectly, proapoptotic (Ji et al, 1999; Sard et al, 1999; Dumon
et al, 2001; Ishii et al, 2001), so perhaps the difference in Fhit-
positive and -negative cells at the G2/M boundary is not in
checkpoint or cycling defects but in sending or responding to an
apoptotic signal. Very recently, it was reported that Noxa-deficient
mice show decreased DNA damage-induced apoptosis in fibro-
blasts (Shibue et al, 2003; Villunger et al, 2003) and Noxa, a BH3-
only member of the BCL2 family, is considered a critical mediator
of the apoptotic response induced by p53 (Oda et al, 2000). Noxa
was not required for normal development since nullizygous mice
were born at the expected frequency and the mice appeared
normal. The role of Noxa in stress-induced apoptosis was
investigated in primary embryo fibroblast cultures by treating
the MEFs with etoposide (CPT11), g-radiation and other agents.
Noxa-deficient MEFs exhibited modest resistance to etoposide-
induced apoptosis, although cancer susceptibility has not yet been
assessed. Also, Noxa  /  mice showed resistance to X-ray-
induced gastrointestinal death, with reduced apoptosis of epithelial
cells of small intestine crypts (Shibue et al, 2003). Thus, Noxa-
deficient mice may have a phenotype similar to Fhit-deficient mice
(Hu et al, 2004), suggesting that the Fhit proapoptotic function
may involve the Noxa pathway.
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